Andreas Lohri

Medicine · Health Sciences

30h-index6.0kcitations113works3.02yr avg
OpenAlex↗Google Scholar↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Lymphoma Diagnosis and Treatment(63), Lung Cancer Treatments and Mutations(28), Chronic Lymphocytic Leukemia Research(24), Viral-associated cancers and disorders(19), CNS Lymphoma Diagnosis and Treatment(10)

Publications112 total

Prolonged rituximab maintenance in follicular lymphoma patients: long-term results of the SAKK 35/03 randomized trial
Blood Advances·2020· 23 citedOpen Access
Prospective long-term follow-up after first-line subcutaneous cladribine in hairy cell leukemia: a SAKK trial
Blood Advances·2020· 30 citedOpen Access
Positron Emission Tomography–Guided Treatment in Early-Stage Favorable Hodgkin Lymphoma: Final Results of the International, Randomized Phase III HD16 Trial by the German Hodgkin Study Group
Journal of Clinical Oncology·2019· 217 cited
PET-Guided Treatment of Early-Stage Favorable Hodgkin Lymphoma: Final Results of the International, Randomized Phase 3 Trial HD16 by the GHSG
International Journal of Radiation Oncology*Biology*Physics·2019· 4 cited
S819 PET AFTER 2 CYCLES OF ABVD IN PATIENTS WITH EARLY-STAGE FAVORABLE HODGKIN LYMPHOMA TREATED WITHIN THE PHASE 3 GHSG HD16 STUDY
HemaSphere·2019· 1 citedOpen Access
Short regimen of rituximab plus lenalidomide in follicular lymphoma patients in need of first-line therapy
Blood·2019· 58 citedOpen Access
Rituximab Maintenance Treatment for a Maximum of 5 Years in Follicular Lymphoma: Final Results of the Randomized Phase III Trial SAKK 35/03
Blood·2018· 1 cited
PET-Guided Treatment of Early-Stage Favorable Hodgkin Lymphoma: Final Results of the International, Randomized Phase 3 Trial HD16 By the German Hodgkin Study Group
Blood·2018· 15 cited
Prospective Long-Term Follow-up after First-Line Subcutaneous Cladribine Treatment in Patients with Hairy Cell Leukemia. a Study of the SAKK (Swiss Group for Clinical Cancer Research)
Blood·2018
Diagnosis and treatment of follicular lymphoma: an update
Swiss Medical Weekly·2018· 18 citedOpen Access
Early Interim PET in Patients with Advanced-Stage Hodgkin's Lymphoma Treated within the Phase 3 GHSG HD18 Study
Blood·2017· 6 cited
Dyslipidemia and lipid-lowering treatment in a hematopoietic stem cell transplant cohort: 25 years of follow-up data
Journal of clinical lipidology·2017· 21 cited
PET-guided treatment in patients with advanced-stage Hodgkin's lymphoma (HD18): final results of an open-label, international, randomised phase 3 trial by the German Hodgkin Study Group
The Lancet·2017· 372 cited
EBEACOPP WITH OR WITHOUT RITUXIMAB IN INTERIM‐PET‐POSITIVE ADVANCED‐STAGE HODGKIN LYMPHOMA: UPDATED RESULTS OF THE INTERNATIONAL, RANDOMIZED PHASE 3 GHSG HD18 TRIAL
Hematological Oncology·2017· 8 citedOpen Access
Progression-free survival of early interim PET-positive patients with advanced stage Hodgkin's lymphoma treated with BEACOPPescalated alone or in combination with rituximab (HD18): an open-label, international, randomised phase 3 study by the German Hodgkin Study Group
The Lancet Oncology·2017· 89 cited
Rituximab Plus Lenalidomide Versus Rituximab Monotherapy in Untreated Follicular Lymphoma Patients in Need of Therapy. First Analysis of Survival Endpoints of the Randomized Phase-2 Trial SAKK 35/10
Blood·2016· 9 cited
Supplementum 216: Diagnosis and treatment of marginal zone lymphoma
Swiss Medical Weekly·2016· 3 citedOpen Access
Lymphome
Praxis·2016· 1 cited
Conditional Survival in Patients with Advanced Pancreatic Cancer
JOP, journal of the pancreas·2016
Rituximab Maintenance for a Maximum of 5 Years After Single-Agent Rituximab Induction in Follicular Lymphoma: Results of the Randomized Controlled Phase III Trial SAKK 35/03
Journal of Clinical Oncology·2015· 62 citedOpen Access
page 1 of 6Next →

Frequent Co-authors

Volker Diehl(15), Andreas Engert(15), Peter Borchmann(13), Michael Fuchs(12), Hans Theodor Eich(10), Felicitas Hitz(10), Michele Ghielmini(10), Richard Greil(8), Jana Marková(7), Richard Herrmann(7), Helen Goergen(6), Carsten Kobe(6), Josée M. Zijlstra(6), Markus Dietlein(6), Emanuele Zucca(6), Walter Mingrone(6), Daniel Rauch(6), Julia Meißner(5), Georg Kuhnert(5), Giovanni Martinelli(5)